Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-16-121183

Director acquired 66,333 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Brady Todd C · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2016-05-18 Conversion : show line 1 in the form +66,333 124,303 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Owned after D/I
2016-05-18 Conversion : show line 2 in the form Series A Preferred Stock −398 $0.00 0 D
Loading xslF345X03/doc4.xml…